HIV Research Today is a free monthly online journal that collates and summarizes the latest research about HIV, including details on human immunodeficiency virus, testing, treatment, prevention, vaccines, aids.

Volume 4 (2007), Issue 6 (June)

1. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
   Obstet Gynecol, 109(6): 1358-67. [Abstract] [Full-text]
2. Remission of progressive multifocal leukoencephalopathy and primary central nervous system lymphoma in an HIV-infected patient.
   Eur J Neurol, 14(6): 598-602. [Abstract] [Full-text]
3. A novel anticancer agent ARC antagonizes HIV-1 and HCV.
   Oncogene, 26(26): 3899-903. [Abstract] [Full-text]
4. A role for mitogen-activated protein kinase and Ets-1 in the induction of interleukin-10 transcription by human immunodeficiency virus-1 Tat.
   Immunology, 121(3): 337-48. [Abstract] [Full-text]
5. A subset of functional effector-memory CD8+ T lymphocytes in human immunodeficiency virus-infected patients.
   Immunology, 121(3): 405-15. [Abstract] [Full-text]
6. Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infection.
   Pharmacotherapy, 27(6): 793-800. [Abstract] [Full-text]
7. Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management.
   Pediatrics, 119(6): e1371-83. [Abstract] [Full-text]
8. Negative elongation factor NELF represses human immunodeficiency virus transcription by pausing the RNA polymerase II complex.
   J Biol Chem, 282(23): 16981-8. [Abstract] [Full-text]
9. Site-specific mutations in HIV-1 gp41 reveal a correlation between HIV-1-mediated bystander apoptosis and fusion/hemifusion.
   J Biol Chem, 282(23): 16899-906. [Abstract] [Full-text]
10. The role of lysine 186 in HIV-1 integrase multimerization.
    Virology, 364(1): 227-36. [Abstract] [Full-text]
11. Survey of the temporal changes in HIV-1 replicative fitness in the Amsterdam Cohort.
    Virology, 364(1): 140-6. [Abstract] [Full-text]
12. Nucleotides within the anticodon stem are important for optimal use of tRNA(Lys,3) as the primer for HIV-1 reverse transcription.
    Virology, 364(1): 169-77. [Abstract] [Full-text]
13. Recombination favors the evolution of drug resistance in HIV-1 during antiretroviral therapy.
    Infect Genet Evol, 7(4): 476-83. [Abstract] [Full-text]
14. Methamphetamine and young men who have sex with men: understanding patterns and correlates of use and the association with HIV-related sexual risk.
    Arch Pediatr Adolesc Med, 161(6): 591-6. [Abstract] [Full-text]
15. Fosamprenavir calcium plus ritonavir for HIV infection.
    Expert Rev Anti Infect Ther, 5(3): 349-63. [Abstract] [Full-text]
16. Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa.
    BMC Infect Dis, 7: 41. [Abstract] [Full-text]
17. Genetic and phenotypic features of blood and genital viral populations of clinically asymptomatic and antiretroviral-treatment-naive clade a human immunodeficiency virus type 1-infected women.
    J Clin Microbiol, 45(6): 1838-42. [Abstract] [Full-text]
18. Isolation of Nocardia asiatica from cutaneous ulcers of a human immunodeficiency virus-infected patient in Italy.
    J Clin Microbiol, 45(6): 2088-9. [Abstract] [Full-text]
19. Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients.
    J Clin Microbiol, 45(6): 1783-8. [Abstract] [Full-text]
20. Multicenter evaluation of the new Abbott RealTime assays for quantitative detection of human immunodeficiency virus type 1 and hepatitis C virus RNA.
    J Clin Microbiol, 45(6): 1712-7. [Abstract] [Full-text]
21. Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil.
    J Clin Microbiol, 45(6): 2061-3. [Abstract] [Full-text]
22. Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone.
    J Gen Intern Med, 22(7): 1003-6. [Abstract] [Full-text]
23. Enhanced production of p24 Gag protein in HIV-1-infected rat cells fused with uninfected human cells.
    Exp Mol Pathol, 83(1): 125-30. [Abstract] [Full-text]
24. Endogenous reactivation and true treatment failure as causes of recurrent tuberculosis in a high incidence setting with a low HIV infection.
    Trop Med Int Health, 12(6): 700-8. [Abstract] [Full-text]
25. Dynamics of CD4+ T cells in HIV-1 infection.
    Immunol Cell Biol, 85(4): 287-94. [Abstract] [Full-text]
26. Failure to establish HIV care: characterizing the "no show" phenomenon.
    Clin Infect Dis, 45(1): 127-30. [Abstract] [Full-text]
27. Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384.
    Clin Infect Dis, 45(1): 120-6. [Abstract] [Full-text]
28. Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study.
    Clin Infect Dis, 45(1): 111-9. [Abstract] [Full-text]
29. HIV infection is associated with an increased risk for lung cancer, independent of smoking.
    Clin Infect Dis, 45(1): 103-10. [Abstract] [Full-text]
30. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole.
    Clin Infect Dis, 45(1): 76-80. [Abstract] [Full-text]
31. Bovine leukemia virus protease: comparison with human T-lymphotropic virus and human immunodeficiency virus proteases.
    J Gen Virol, 88: 2052-63. [Abstract] [Full-text]
32. A new strategy to inhibit the excision reaction catalysed by HIV-1 reverse transcriptase: compounds that compete with the template-primer.
    Biochem J, 405(1): 165-71. [Abstract] [Full-text]
33. Evolution of a novel 5-amino-acid insertion in the beta3-beta4 loop of HIV-1 reverse transcriptase.
    Virology, 364(2): 395-406. [Abstract] [Full-text]
34. The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains.
    Virology, 364(2): 486-93. [Abstract] [Full-text]
35. ICAM-3 influences human immunodeficiency virus type 1 replication in CD4(+) T cells independent of DC-SIGN-mediated transmission.
    Virology, 364(2): 383-94. [Abstract] [Full-text]
36. Cell surface expression of CCR5 and other host factors influence the inhibition of HIV-1 infection of human lymphocytes by CCR5 ligands.
    Virology, 364(2): 281-90. [Abstract] [Full-text]
37. Entry inhibitor-based microbicides are active in vitro against HIV-1 isolates from multiple genetic subtypes.
    Virology, 364(2): 431-40. [Abstract] [Full-text]
38. Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis.
    Virology, 364(2): 441-53. [Abstract] [Full-text]
39. Fisher/Gullain-Barré overlap syndrome in advanced AIDS.
    J Neurol Sci, 258(1): 148-50. [Abstract] [Full-text]
40. Replicating a teen HIV/STD preventive intervention in a multicultural city.
    AIDS Educ Prev, 19(3): 258-73. [Abstract] [Full-text]
41. Injection drug users' strategies to manage perceptions of personal risk: how do IDUs see HIV as having affected them?
    AIDS Educ Prev, 19(3): 245-57. [Abstract] [Full-text]
42. Association between exposure to an HIV story line in The Bold and the Beautiful and HIV-related stigma in Botswana.
    AIDS Educ Prev, 19(3): 209-17. [Abstract] [Full-text]
43. Measurement of stigma in people with HIV: a reexamination of the HIV Stigma Scale.
    AIDS Educ Prev, 19(3): 198-208. [Abstract] [Full-text]
44. Effectiveness of antenatal group HIV voluntary counseling and testing services in rural India.
    AIDS Educ Prev, 19(3): 187-97. [Abstract] [Full-text]
45. Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy.
    Neurology, 68(24): 2113-9. [Abstract] [Full-text]
46. Antimicrobial resistance predicts death in Tanzanian children with bloodstream infections: a prospective cohort study.
    BMC Infect Dis, 7: 43. [Abstract] [Full-text]
47. Exposure to HIV in Brazilian adolescents: the impact of psychiatric symptomatology.
    Eur Child Adolesc Psychiatry, 16(4): 236-42. [Abstract] [Full-text]
48. Pregnancy outcomes and antiretroviral treatment in a national cohort of pregnant women with HIV: overall rates and differences according to nationality.
    BJOG, 114(7): 896-900. [Abstract] [Full-text]
49. A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas.
    J Virol, 81(13): 7280-5. [Abstract] [Full-text]
50. Multiple restrictions of human immunodeficiency virus type 1 in feline cells.
    J Virol, 81(13): 7048-60. [Abstract] [Full-text]
51. Activated CD34-derived Langerhans cells mediate transinfection with human immunodeficiency virus.
    J Virol, 81(13): 6858-68. [Abstract] [Full-text]
52. Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivo.
    J Virol, 81(13): 6947-56. [Abstract] [Full-text]
53. Mutations in human immunodeficiency virus type 1 RNase H primer grip enhance 3'-azido-3'-deoxythymidine resistance.
    J Virol, 81(13): 6837-45. [Abstract] [Full-text]
54. Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration.
    J Virol, 81(13): 7099-110. [Abstract] [Full-text]
55. Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.
    J Virol, 81(13): 7238-48. [Abstract] [Full-text]
56. Direct comparison of antigen production and induction of apoptosis by canarypox virus- and modified vaccinia virus ankara-human immunodeficiency virus vaccine vectors.
    J Virol, 81(13): 7022-33. [Abstract] [Full-text]
57. Podocytes in HIV-associated nephropathy.
    Nephron Clin Pract, 106(2): c67-71. [Abstract] [Full-text]
58. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes.
    Lancet, 369(9578): 2042-9. [Abstract] [Full-text]
59. Genetic and phylogenetic evolution of HIV-1 in a low subtype heterogeneity epidemic: the Italian example.
    Retrovirology, 4: 34. [Abstract] [Full-text]
60. Identification of the suppressive factors for human immunodeficiency virus type-1 replication using the siRNA mini-library directed against host cellular genes.
    Biochem Biophys Res Commun, 359(3): 729-34. [Abstract] [Full-text]
61. HIV viral dynamic models with dropouts and missing covariates.
    Stat Med, 26(17): 3342-57. [Abstract] [Full-text]
62. HIV prevention education and testing among youth: is there a correlation?
    J Adolesc Health, 41(1): 105-7. [Abstract] [Full-text]
63. Langerhans cell density and high-grade vulvar intraepithelial neoplasia in women with human immunodeficiency virus infection.
    J Cutan Pathol, 34(7): 565-70. [Abstract] [Full-text]
64. Efavirenz to nevirapine switch in HIV-1-infected patients with dyslipidemia: a randomized, controlled study.
    Clin Infect Dis, 45(2): 263-6. [Abstract] [Full-text]
65. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa.
    Clin Infect Dis, 45(2): 254-60. [Abstract] [Full-text]
66. Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005.
    Clin Infect Dis, 45(2): 241-9. [Abstract] [Full-text]
67. Influenzavirus infection is a primary cause of febrile respiratory illness in HIV-infected adults, despite vaccination.
    Clin Infect Dis, 45(2): 234-40. [Abstract] [Full-text]
68. AIDS-related cancer and severity of immunosuppression in persons with AIDS.
    J Natl Cancer Inst, 99(12): 962-72. [Abstract] [Full-text]
69. The HBV drug entecavir - effects on HIV-1 replication and resistance.
    N Engl J Med, 356(25): 2614-21. [Abstract] [Full-text]
70. Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children.
    BMC Infect Dis, 7: 55. [Abstract] [Full-text]
71. Safety trial of the vaginal microbicide cellulose sulfate gel in HIV-positive men.
    Sex Transm Dis, 34(7): 519-22. [Abstract] [Full-text]
72. Risk factors for genital and anal warts in a prospective cohort of HIV-negative homosexual men: the HIM study.
    Sex Transm Dis, 34(7): 488-93. [Abstract] [Full-text]
73. Functional T cell subsets contribute differentially to HIV peptide-specific responses within infected individuals: correlation of these functional T cell subsets with markers of disease progression.
    Clin Immunol, 124(1): 57-68. [Abstract] [Full-text]
74. iRED analysis of TAR RNA reveals motional coupling, long-range correlations, and a dynamical hinge.
    Biophys J, 93(2): 411-22. [Abstract] [Full-text]
75. Healthcare utilization of patients accessing an African national treatment program.
    BMC Health Serv Res, 7: 80. [Abstract] [Full-text]
76. HIV integrase inhibitors as therapeutic agents in AIDS.
    Rev Med Virol, 17(4): 277-95. [Abstract] [Full-text]
77. Evaluation of the substrate envelope hypothesis for inhibitors of HIV-1 protease.
    Proteins, 68(2): 561-7. [Abstract] [Full-text]
78. Establishing an ED HIV screening program: lessons from the front lines.
    Acad Emerg Med, 14(7): 658-61. [Abstract] [Full-text]
79. Acute human immunodeficiency virus infection in a breast-fed infant in New York City.
    Pediatr Infect Dis J, 26(7): 653-5. [Abstract] [Full-text]
80. Missed opportunities for prevention of mother-to-child transmission of human immunodeficiency virus type 1 in Latin America and the Caribbean: the NISDI perinatal study.
    Pediatr Infect Dis J, 26(7): 649-53. [Abstract] [Full-text]
81. Testing the limits of case finding for HIV prevention.
    Lancet Infect Dis, 7(7): 491-5. [Abstract] [Full-text]
82. Monitoring the dynamics of the HIV epidemic using assays for recent infection and serotyping among new HIV diagnoses: experience after 2 years in France.
    J Infect Dis, 196(3): 377-83. [Abstract] [Full-text]
83. Mitochondrial DNA decline in T cells of HIV-1 seroconverters may be dependent on immune activation.
    J Infect Dis, 196(3): 371-6. [Abstract] [Full-text]
84. Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV.
    J Infect Dis, 196(3): 361-70. [Abstract] [Full-text]
85. Long-term persistence of transmitted HIV drug resistance in male genital tract secretions: implications for secondary transmission.
    J Infect Dis, 196(3): 356-60. [Abstract] [Full-text]
86. Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study.
    J Infect Dis, 196(3): 347-55. [Abstract] [Full-text]
87. Predictors of influenza vaccination in HIV-infected patients in the United States, 1990-2002.
    J Infect Dis, 196(3): 339-46. [Abstract] [Full-text]
88. HIV-1 proviral DNA excision using an evolved recombinase.
    Science, 316(5833): 1912-5. [Abstract] [Full-text]
89. Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery.
    Science, 316(5833): 1908-12. [Abstract] [Full-text]
90. Determining the effect of highly active antiretroviral therapy on changes in human immunodeficiency virus type 1 RNA viral load using a marginal structural left-censored mean model.
    Am J Epidemiol, 166(2): 219-27. [Abstract] [Full-text]
91. Persistence of nevirapine in breast milk after discontinuation of treatment.
    Clin Infect Dis, 45(3): 391-4. [Abstract] [Full-text]
92. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
    Clin Infect Dis, 45(3): 381-90. [Abstract] [Full-text]
93. Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs.
    Clin Infect Dis, 45(3): 370-6. [Abstract] [Full-text]
94. The influence of hormonal contraceptive use on HIV-1 transmission and disease progression.
    Clin Infect Dis, 45(3): 360-9. [Abstract] [Full-text]
95. Incidence and persistence of Staphylococcus aureus nasal colonization in a community sample of HIV-infected and -uninfected drug users.
    Clin Infect Dis, 45(3): 343-6. [Abstract] [Full-text]

© 2004-2008 HIV Research Today. All Rights Reserved.